Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Kezar Life Sciences (KZR) Other Operating Expenses (2023 - 2024)

Kezar Life Sciences' Other Operating Expenses history spans 2 years, with the latest figure at -$12000.0 for Q4 2024.

  • For Q4 2024, Other Operating Expenses fell 100.19% year-over-year to -$12000.0; the TTM value through Sep 2025 reached -$12000.0, down 100.16%, while the annual FY2024 figure was $1.5 million, 76.24% down from the prior year.
  • Other Operating Expenses for Q4 2024 was -$12000.0 at Kezar Life Sciences, down from $1.5 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $6.2 million in Q4 2023 and bottomed at -$12000.0 in Q4 2024.